Logo
PEGFILGRASTIM BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
  2. / Industry Reports
  3. Pegfilgrastim Biosimilars Market Analysis
all report title image

PEGFILGRASTIM BIOSIMILARS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Aug 2024
  • Code : CMI7242
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Pegfilgrastim Biosimilars Market Concentration By Players

Close-monitor your Competitor's Move, Get Instant Access to the Report

Key Players Insights
  • Coherus BioSciences
  • Mylan N.V.
  • Biocon
  • Sandoz (a Novartis division)
  • Pfizer Inc.
  • Apotex Inc.
  • Cinfa Biotech
  • Gedeon Richter
  • Stada Arzneimittel AG
  • Mundipharma
  • Aurobindo Pharma
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Intas Pharmaceuticals
  • Biocad
  • Genor Biopharma
  • Qilu Pharmaceutical
  • Henlius Biotech

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.